Moderate riskFDA DrugClass III

Somerset Therapeutics cisatracurium besylate injection recalled for subpotent drug strength

Somerset Therapeutics is recalling specific lots of cisatracurium besylate injection because testing found the drug contains less active ingredient than labeled. The affected vials may not work as intended during medical procedures. No injuries have been reported.

From the FDA notice · Read the official notice ↗

What to do

  1. If you have cisatracurium besylate with lot A240438 (expires 1/31/26) or A250125 (expires 8/31/26), do not use it
  2. Contact your pharmacy or hospital to verify whether your supply is affected
  3. Follow your healthcare provider's instructions for alternative medications if needed

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Cisatracurium Besylate Injection USP, 10 mg/5 mL* (2mg/mL), 10 x 5 mL Single-dose Vials per Carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India, Single-dose 5 mL vial NDC 70069-141-01; 10x5 mL single dose vial per Carton NDC 70069-141-10.
Sold in
Nationwide
Made for
All ages (0 months and older)

This recall covers 3 products — see all of them.

Details

Units affected
52,340 5mL vials
Illnesses reported
None reported
Manufactured in
300 Franklin Square Dr, Somerset, NJ, United States
Classification
Class III
Recall number
D-0236-2026

In the FDA's words

Description
Cisatracurium Besylate Injection USP, 10 mg/5 mL* (2mg/mL), 10 x 5 mL Single-dose Vials per Carton, Rx Only, Manufactured for: Somerset Therapeutics, LLC, Hollywood, FL 33024, Made in India, Single-dose 5 mL vial NDC 70069-141-01; 10x5 mL single dose vial per Carton NDC 70069-141-10. Subpotent product:out of specification assay results observed during long term stability testing. Lot#: A240438, Exp Date 1/31/26, A250125, Exp Date 8/31/26 Distribution: Nationwide in the USA Affected quantity: 52,340 5mL vials
Hazard
Subpotent product:out of specification assay results observed during long term stability testing.

3 products in this recall

Somerset cisatracurium injection recalled for low potency

Somerset Therapeutics is recalling three cisatracurium besylate injection products because testing found the drug may be weaker than its label states. The recall covers 10 mg/5 mL, 200 mg/20 mL and 20 mg/10 mL vials, all made by Somerset Therapeutics in India and distributed nationwide. No injuries have been reported.

The agency lists each product separately. Check every one you might have.

Related topics

PotencyDrugsSold nationwideMore from FDA Drug